Tag Archives: Ortho Biotech

Novel Agent Significantly Improves Survival in Men with Advanced Prostate Cancer

Great news for patients with advanced prostate cancer.  A new investigational agent, abiraterone acetate, was shown to significantly improved survival in men with metastatic castration-resistant prostate cancer.  Abiraterone acetate is an investigational agent being developed by Ortho Biotech.  It acts … Continue reading

Posted in Cancer, Prostate cancer | Tagged , , , , , , , , | Comments Off on Novel Agent Significantly Improves Survival in Men with Advanced Prostate Cancer